Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-26.01	11.56	15.62
Graham Fair Price	-26.58	5955.89	8112.08
PEG	233.72	-0.03	0.01
Price/Book	-4.90	0.24	0.25
Price/Cash Flow	153.30	-34.50	13.62
Prices/Earnings	81.80	5.22	-2.87
Price/Sales	-5.95	0.91	0.97
Price/FCF	153.30	-34.50	13.62
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	13.80	0.09	0.08
Operating Margin	172.55	0.03	< 0.005
ROA	-47.37	< 0.005	-0.01
ROE	-0.02	0.01	-47.69
ROIC	< 0.005	< 0.005	15.32
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.08	-0.14	43.95
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	2.30	1.80	-21.86
EPS QOQ	-2.81	1.53	-45.52
FCF QOQ	1.73	-1.38	-20.15
Revenue QOQ	-0.02	0.03	39.49
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	62.72	63.07	0.57
Days Sales Outstanding (DSO)	51.59	59.86	16.02
Inventory Turnover	1.44	1.43	-0.57
Debt/Capitalization	0.05	0.05	-10.18
Quick Ratio	2.27	2.35	3.84
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	11626.62	11802.49	1.51
Cash	3780.28	3524.10	-6.78
Capex	-68.79	-117.73	-71.13
Free Cash Flow	212.21	-80.88	-61.89
Revenue	2989.85	3069.04	2.65
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	3.06	3.20	4.52
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.39	0.25	-34.53
Naive Interpretation	Member

06 - Financial Health · Bad

Rating